BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Business

  ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014

  December 22, 2014

   · 

  1 min read
• Drug Development

  AGA’s GERD Registry Enrolls First Patients

  December 22, 2014

   · 

  6 min read
• BrainStorm Cell Therapeutics Inc. To Host Conference Call To Discuss Final Results Of Phase 2a Trial Of NurOwn™ In ALS On January 5, 2015

  December 22, 2014

   · 

  4 min read
• Business

  EpiVax, Inc. Enters License Agreement With Novozymes Biopharma To Advance Pioneering Treatment Of Autoimmune Diseases

  December 22, 2014

   · 

  4 min read
• Drug Development

  MediGene AG Receives Clinical Trial Approval For Phase I/II Study With DC Vaccine To Treat Acute Myeloid Leukaemia (AML)

  December 22, 2014

   · 

  3 min read
• Business

  Actavis Names Jonathon Kellerman Executive Vice President, Global Chief Compliance Officer

  December 22, 2014

   · 

  3 min read
• Business

  Tiziana Life Sciences Plc Licenses Foralumab From NovImmune SA

  December 22, 2014

   · 

  5 min read
• Biotech Bay

  InSite Vision Announces Date For Annual Stockholder Meeting

  December 22, 2014

   · 

  1 min read
• Business

  Covidien Declares Quarterly Cash Dividend

  December 22, 2014

   · 

  1 min read
• Business

  ImmunoGen, Inc. Appoints Richard J. Gregory, Ph.D. As EVP, Chief Scientific Officer; John M. Lambert, Ph.D. Named EVP, Distinguished Research Fellow

  December 22, 2014

   · 

  1 min read